Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present BioCardia, Inc. (OTC: BCDA).

Full DD Report for BCDA

You must become a subscriber to view this report.

Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BCDA.

About BioCardia, Inc. (OTC: BCDA)

Logo for BioCardia, Inc. (OTC: BCDA)

BioCardia, Inc. is a clinical stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. Its lead therapeutic candidate is the CardiAMP cell therapy system and its second therapeutic candidate is the CardiALLO cell therapy system. BioCardia is headquartered in San Carlos, California.


Contact Information



Current Management

  • Peter Alan Altman / CEO, President
  • David McClung / CFO
  • Henricus Johannes Duckers / CMO
  • Ivone Chanu / Manager
  • Richard Thomas Allen / Other
  • Simon H. Stertzer / Chairman, Independent Director
  • Peter Alan Altman /
  • Fernando L. Fernandez / Independent Director, Audit Committee Member
  • Richard Pfenniger, Jr. / Independent Director, Compensation Committee Member
  • Richard M. Krasno / Independent Director
  • Jay M. Moyes / Independent Director, Audit Committee Member, Compensation Committee Member
  • Thomas Quertermous / Independent Director
  • Allan Roger Tessler / Independent Director, Audit Committee Member

Current Share Structure

  • Market Cap: $74,562,175 - 03/15/2018
  • Authorized: 100,000,000 - 03/12/2018
  • Issue and Outstanding: 38,237,013 - 03/12/2018


Recent Filings from (OTC: BCDA)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 27 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: April, 20 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 16 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 12 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: February, 05 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 09 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: November, 07 2017
All other definitive information statements
Filing Type: DEF 14CFiling Source: edgar
Filing Date: October, 10 2017
Preliminary proxy statement containing all other information
Filing Type: PRE 14CFiling Source: edgar
Filing Date: September, 26 2017



Daily Technical Chart for (OTC: BCDA)

Daily Technical Chart for (OTC: BCDA)

Stay tuned for daily updates and more on (OTC: BCDA)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BCDA)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BCDA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BCDA and does not buy, sell, or trade any shares of BCDA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: